Pursuant to section 4729.01 of the Revised Code, the state board of pharmacy hereby designates the following dangerous drugs, which have been approved by the federal food and drug administration for the reversal of a known or suspected opioid-related overdose, as overdose reversal drugs:
(A) Naloxone; and
(B) Nalmefene.
Last updated October 31, 2023 at 9:21 AM